IZCARGO<sup>Ⓡ</sup>: the world's first biological drug applied with brain drug delivery technology
-
- Sonoda Hiroyuki
- Research Division, JCR Pharmaceuticals Co., Ltd.
-
- Minami Kohtaro
- Research Division, JCR Pharmaceuticals Co., Ltd.
Bibliographic Information
- Other Title
-
- イズカーゴ<sup>Ⓡ</sup> ―脳へのドラッグデリバリー技術を適用した世界初の医薬品―
Abstract
Most drugs cannot be delivered to the brain from the systemic circulation due to the presence of the blood-brain barrier, and therefore it is quite challenging to develop therapeutics addressing central nervous system disorders. IZCARGOⓇ(general name: pabinafusp alfa) is the world’s first biological drug applied with the brain drug delivery technology J-Brain CargoⓇ, which utilizes the transferrin receptor-mediated Fe/transferrin transport to the brain, and was launched in Japan in May 2021 to treat patients with all forms of MPS II. The drug is a fusion protein consisting of anti-human transferrin receptor antibody and iduronate-2-sulfatase and penetrates the blood-brain barrier into the brain parenchyma where it exerts pharmacological effects. J-Brain CargoⓇ is a fundamental technology for drug delivery to the central nervous system, and its application is expected to be expanded to various diseases.
Journal
-
- Drug Delivery System
-
Drug Delivery System 38 (1), 68-74, 2023-01-25
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390858829329390208
-
- ISSN
- 18812732
- 09135006
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
-
- Abstract License Flag
- Disallowed